Early-onset Alzheimer's is a rare form of dementia that occurs between ages 30 and 60, and may affect several members of a single family.| Alzheimer's News Today
Patricia Inacio is a science writer for Alzheimer's News Today with a PhD in cell biology. She covers the latest news and information on a variety of Alzheimer's topics.| Alzheimer's News Today
Steve Bryson is a science writer for Alzheimer's News Today with a PhD in biochemistry. He covers the latest news and information on a variety of Alzheimer's topics.| Alzheimer's News Today
The immunotherapy Leqembi, formerly BAN2401, is now FDA-approved for slowing cognitive decline in patients with Alzheimer's disease.| Alzheimer's News Today
Category archive page for News.| Alzheimer's News Today
